Frederick M. Hudson - 19 Feb 2022 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Jack A. Khattar, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
19 Feb 2022
Transactions value $
$0
Form type
4
Filing time
23 Feb 2022, 15:16:46 UTC
Previous filing
10 Jun 2021
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Award $0 +4.22K +23.4% $0.00 22.3K 19 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Restricted Stock Units Disposed to Issuer $0 -4.22K -100% $0.00* 0 19 Feb 2022 Common Stock 4.22K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F2 These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022.